Literature DB >> 27830965

Incidence and risk factors for cervical lesions in patients with rheumatoid arthritis under the current pharmacologic treatment paradigm.

Takashi Kaito1, Shirou Ohshima2, Hiroyasu Fujiwara3, Takahiro Makino1, Kazuo Yonenobu4, Hideki Yoshikawa1.   

Abstract

OBJECTIVE: To elucidate the incidence and risk factors for cervical lesions in patients with rheumatic arthritis (RA) under the current pharmacologic treatment paradigm.
METHODS: Of patients with RA onset after 2000, 151 who introduced biologic agents (BAs) because of high disease activity and underwent cervical radiography more than 5 years after onset were included. Incidence of those with cervical lesions and predictors of cervical lesions were analyzed. Mean disease duration was 8.5 years. The radiographic definitions of cervical lesions were as follows: atlantoaxial subluxation (AAS), atlantodental interval >3 mm; vertical subluxation (VS), Ranawat value <13 mm; and subaxial subluxation (SS), and listhesis >2 mm.
RESULTS: Radiographic evaluation indicated AAS in 43 cases (28%), VS in 10 (7%), and SS in 6 (4%). The incidence of those with any cervical lesion was 32% (48/151). Univariate analysis showed that disease duration, time from onset to BA use, and onset before 2005 were significant predictors of cervical lesions, while multivariate regression analysis showed that disease duration and Steinbrocker stage were predictors.
CONCLUSION: The incidence of cervical lesions in patients with RA onset after 2000 was still high (32%). In addition, disease duration and Steinbrocker stage were predictors of cervical lesions.

Entities:  

Keywords:  Biologic agents; Cervical lesion; Incidence; Predictor; Rheumatoid arthritis

Mesh:

Substances:

Year:  2016        PMID: 27830965     DOI: 10.1080/14397595.2016.1253649

Source DB:  PubMed          Journal:  Mod Rheumatol        ISSN: 1439-7595            Impact factor:   3.023


  6 in total

1.  [Population distribution and clinical characteristics in rheumatoid arthritis patients with cervical spine instability].

Authors:  L Zhang; X H Hu; Q W Wang; Y M Cai; J X Zhao; X Y Liu
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2020-12-18

2.  Risk factors for cervical spine instability in patients with rheumatoid arthritis.

Authors:  In-Woon Baek; Young Bin Joo; Kyung-Su Park; Ki-Jo Kim
Journal:  Clin Rheumatol       Date:  2020-06-29       Impact factor: 2.980

3.  Bioequivalence of the pharmacokinetics between tofacitinib aspartate and tofacitinib citrate in healthy subjects.

Authors:  Wonsuk Shin; A-Young Yang; Hyeonji Yun; Doo-Yeoun Cho; Kyung Hee Park; Hyunju Shin; Anhye Kim
Journal:  Transl Clin Pharmacol       Date:  2020-09-21

Review 4.  The Influence of Reducing Disease Activity Score on Cervical Spine Deformity in Rheumatoid Arthritis: A Systematic Review.

Authors:  Anna B Veldman; Cornelia F Allaart; Carmen L A Vleggeert-Lankamp
Journal:  Biomed Res Int       Date:  2022-04-15       Impact factor: 3.246

5.  Risk factors associated with cervical spine lesions in patients with rheumatoid arthritis: an observational study.

Authors:  Yosuke Uchino; Takayuki Higashi; Naomi Kobayashi; Tetsuhiko Inoue; Yuichi Mochida; Yutaka Inaba
Journal:  BMC Musculoskelet Disord       Date:  2021-05-03       Impact factor: 2.362

6.  A not-to-miss Cause of Severe Cervical Spine Pain in a Patient with Rheumatoid Arthritis: A Case-Based Review.

Authors:  Alexandros A Drosos; Eleftherios Pelechas; Athanasios N Georgiadis; Paraskevi V Voulgari
Journal:  Mediterr J Rheumatol       Date:  2021-08-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.